|
It was reported that prior to the attempted implant of a transcatheter aortic valve, a pre-implant balloon aortic valvuloplasty was performed due to calcification.During the first deployment attempt, inside the patient's native annulus, the valve dislodged and subsequently was recaptured.During the second deployment attempt, the valve was deployed at the target implant depth of 4 millimeter¿s (mm) on the non-coronary cusp (ncc) and 4 mm on the left coronary cusp (lcc).Prior to withdrawing the delivery catheter system (dcs), the nose cone was centered within the frame inflow by slightly retracting the medtronic guidewire.Following the implant of the valve, as the delivery catheter system (dcs) was withdrawn, the nose cone interacted with the outflow of the valve and subsequently the valve dislodged to the ascending aorta resulting in paravalvular leak (pvl).The dislodged valve was snared and a second system was used to cross the first valve.During the attempted implant of the second valve, an aortic dissection was observed during an aortic root shot.The patient was converted to open heart surgery, and the ascending aorta was repaired to address the dissection.The dislodged valve was explanted and a surgical valve was implanted.It was noted that a 1 hour procedural delay occurred while the dislodged valve was snared and the second valve deployment was attempted.
|
|
D10.Continuation - concomitant medical devices in use during the event include: medtronic product id: evfxplus-26; product serial/lot number: (b)(6); product type: 0195-heart valves; implant date: b)(6) 2026; explant date: b)(6) 2026 medtronic product id: d-evolutfx-2329; product serial/lot number: (b)(6); product type: 0195-heart valves; implant date: non-imp lantable; explant date: non-implantable medtronic product id: evfxplus-26; product serial/lot number: unknown; product type: 0195-heart valves; implant date: na; explant date: na medtronic product id: gwbc30; product serial/lot number: unknown; product type: 0195-heart valves; implant date: non-implantable; explant date: non-implantable medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|